+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
FeLV Vaccine Market by Vaccine Type (Live Attenuated Vaccine, Recombinant Vaccine, Subunit Vaccine), End User (Research Centers, Veterinary Clinics, Veterinary Hospitals), Distribution Channel, Administration Route, Form, Dosage - Global Forecast 2025-2030- Product Image
FeLV Vaccine Market by Vaccine Type (Live Attenuated Vaccine, Recombinant Vaccine, Subunit Vaccine), End User (Research Centers, Veterinary Clinics, Veterinary Hospitals), Distribution Channel, Administration Route, Form, Dosage - Global Forecast 2025-2030- Product Image
New

FeLV Vaccine Market by Vaccine Type (Live Attenuated Vaccine, Recombinant Vaccine, Subunit Vaccine), End User (Research Centers, Veterinary Clinics, Veterinary Hospitals), Distribution Channel, Administration Route, Form, Dosage - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6147164
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The field of feline leukemia virus (FeLV) vaccination has undergone significant evolution, shaped by groundbreaking research, regulatory developments, and shifting stakeholder expectations. Emerging technologies have accelerated the development of safer and more effective immunization solutions, while veterinary professionals increasingly emphasize a holistic approach to disease prevention. This introduction outlines the critical factors influencing innovation and adoption trends within the FeLV vaccine landscape.

At the molecular level, advances in recombinant and subunit vaccine platforms have addressed long-standing safety concerns associated with live attenuated formulations. Concurrently, heightened collaboration among research institutions, veterinary clinics, and pharmaceutical developers has fostered a robust environment for knowledge exchange and rapid iteration. As the market matures, attention has turned toward optimizing distribution channels, refining administration protocols, and aligning product attributes with end users specific requirements. This multifaceted transformation underscores the need for a comprehensive analysis of the forces driving the next generation of FeLV vaccines and the strategic imperatives for industry stakeholders.

Examining Transformative Shifts in the Feline Leukemia Vaccine Landscape Featuring Emerging Technologies and Protocol Innovations Driving Enhanced Protection

Recent years have seen transformative shifts in the FeLV vaccine landscape, anchored by both scientific breakthroughs and practical considerations at the point of care. Novel antigen expression systems and adjuvant technologies have redefined efficacy benchmarks, enabling broader immunogenic coverage and reduced adverse event profiles. These technological advancements have, in turn, influenced veterinary practice standards, prompting refined dosing schedules and mixed vaccine regimens that prioritize long-term immunity.

Simultaneously, evolving clinical protocols reflect a deeper understanding of feline immunology and behavioral factors that affect compliance. Digital tools for appointment management and real-time adverse reaction reporting are streamlining the vaccination process, while telehealth consultations guide pet owners through preventive strategies. As these trends converge, stakeholders are challenged to integrate cross-functional expertise-from molecular biology to veterinary informatics-to remain competitive. The interplay between innovation and implementation thus frames the most significant shifts reshaping FeLV vaccination strategies today.

Analyzing the Cumulative Impact of New United States Tariffs on Feline Leukemia Vaccine Supply Chains Through 2025 Spearheading Strategic Industry Adaptation

The introduction of new United States tariffs in 2025 has exerted a cumulative impact on the FeLV vaccine supply chain, compelling stakeholders to revisit procurement strategies and cost management frameworks. Increased import duties on raw materials and biologics have elevated production expenses, prompting manufacturers to adapt sourcing models and negotiate revised terms with suppliers. These changes have rippled through distribution networks, affecting manufacturer pricing structures and end user affordability.

In response, several vaccine developers have accelerated investments in domestic manufacturing capacity, reducing reliance on tariff-exposed imports and ensuring continuity of supply. At the same time, contract research organizations and veterinary clinics have pursued collaborative procurement agreements to secure volume discounts. Although price adjustments have been necessary to maintain margin integrity, strategic adaptation and proactive stakeholder engagement have mitigated potential disruptions. This analysis underscores the importance of flexible supply chain design and dynamic pricing mechanisms in navigating tariff-driven market volatility.

Unlocking Key Segmentation Insights into Vaccine Type End Users Distribution Channels Administration Routes Form Factors and Dosage Impacting Market Positioning

Insights across vaccine type reveal that live attenuated formulations continue to offer robust immunogenicity but require stringent cold chain management and carry residual safety considerations. Recombinant vaccines, by contrast, strike a balance between safety and efficacy, benefiting from scalable manufacturing and regulatory acceptance. Subunit vaccines have emerged as an attractive option for high-risk populations, delivering targeted antigenic components with minimal reactogenicity.

Examining end users, research centers drive early-stage innovation, emphasizing molecular profiling and comparative immunology studies. Veterinary clinics prioritize patient throughput and operational efficiency, tailoring vaccine offerings to owner preferences and clinic workflow. Veterinary hospitals integrate FeLV prevention within comprehensive care models, leveraging specialized administration routes and supportive clinical services to enhance compliance.

Distribution channel dynamics are reshaped by digital transformation, as online stores-including e-pharmacies and manufacturer websites-provide on-demand access to vaccine products and educational resources. Veterinary clinics and hospitals maintain a critical role in administering vaccines and monitoring post-vaccination outcomes.

Administration routes bifurcate into intramuscular injections that support deep tissue delivery and subcutaneous options favored for ease of use and patient comfort. Form considerations, whether liquid or lyophilized, influence storage requirements and dosing accuracy, while dosage formats ranging from multi-dose vials to single-use presentations address both cost-efficiency and safety protocols.

In-Depth Regional Analysis Highlighting Growth Drivers and Adoption Patterns Across the Americas Europe Middle East Africa and Asia-Pacific Markets

Regional dynamics across the Americas highlight strong uptake of novel FeLV vaccines in urban veterinary networks, supported by widespread pet insurance adoption and growing owner awareness. Latin American markets reveal steady expansion driven by targeted educational campaigns and government-supported animal health initiatives. Meanwhile, North American players continue to refine product portfolios through strategic alliances and practice-level integration of digital health tools.

In Europe, Middle East & Africa, regulatory harmonization under EU directives and Gulf Cooperation Council standards has streamlined approval processes, fostering rapid market entry for advanced vaccine platforms. Key growth corridors in Sub-Saharan Africa are characterized by pilot programs that integrate FeLV vaccination with broader zoonotic disease control efforts. Collaborative frameworks between veterinary associations and nonprofit organizations underpin regional immunization drives.

Asia-Pacific presents a diverse landscape, as mature markets in Japan and Australia lead in next-generation recombinant vaccines, while emerging economies such as India and Southeast Asian nations invest in capacity-building for domestic vaccine production. Cross-border trade agreements and public-private partnerships accelerate distribution efficiency, enabling wider reach into rural and peri-urban communities. These regional insights illustrate the necessity of tailored strategies to navigate regulatory environments, infrastructure capabilities, and cultural adoption patterns.

Strategic Profiles of Leading Innovators Driving Feline Leukemia Vaccine Research Development and Commercialization Influencing Industry Competition

Leading players have positioned themselves at the nexus of innovation and commercialization, leveraging proprietary antigen discovery platforms and scalable expression systems to advance pipeline candidates. Collaboration between biotech specialists and established animal health companies has emerged as a critical driver of value creation, enabling seamless technology transfer and co-development agreements. Key innovators are deploying integrated digital tools for monitoring vaccine performance, facilitating real-time pharmacovigilance and adherence tracking.

Strategic partnerships with contract manufacturing organizations have expanded global production footprints, ensuring rapid scalability and risk diversification. Emerging entrants are focusing on niche subunit platforms, targeting high-efficacy formulations for immunocompromised felines. Established industry giants are reinforcing their offerings through incremental improvements in adjuvant profiles and delivery mechanisms. Collectively, these initiatives are reshaping competitive dynamics, with a clear emphasis on pipeline depth, regulatory agility, and customer-centric service models.

Actionable Recommendations for Industry Leaders to Navigate Regulatory Hurdles Enhance Vaccine Development and Accelerate Adoption of Feline Leukemia Prevention

Industry leaders should prioritize adaptive regulatory engagement by building strong channels with authorities to anticipate policy changes and streamline approval timelines. Implementing modular manufacturing facilities will enable rapid response to supply chain disruptions, balancing domestic production with selective global sourcing. To enhance vaccine efficacy, cross-functional teams must integrate translational research insights into formulation design, optimizing adjuvant selection and antigen stability.

Embracing digital health ecosystems can bolster patient tracking and compliance, as telemedicine platforms provide education and follow-up capabilities. Organizations should invest in targeted outreach to veterinary professionals through evidence-based continuing education programs, positioning new vaccine platforms within clinical guidelines. Collaborative consortia across industry, academia, and non-profits can drive cost-effective safety monitoring and expand FeLV prevention efforts in underserved regions.

By aligning commercial strategies with evolving pet owner expectations and leveraging data-driven decision making, industry leaders can accelerate market adoption and secure long-term growth. These actionable recommendations provide a roadmap for stakeholders to transform challenges into opportunities and solidify their leadership positions.

Comprehensive Research Methodology Highlighting Data Collection Techniques Analytical Models Expert Interviews and Validation Protocols

This research combines a multi-layered approach, beginning with primary data gathered through structured interviews with virologists, veterinary clinicians, and supply chain experts. Secondary sources include peer-reviewed journals, regulatory filings, and clinical trial registries, providing a robust foundation for analytical rigor. Quantitative datasets were analyzed using advanced statistical models to identify correlation patterns between formulation variables and field performance metrics.

Key assumptions were validated through expert consultations, ensuring that emerging trends were accurately contextualized. Scenario analysis techniques assessed the potential effects of regulatory shifts and tariff changes on cost structures and supply chain resilience. A dedicated validation protocol, incorporating feedback loops from advisory panels, refined the findings and mitigated bias. This integrated methodology underscores the depth and reliability of the insights presented, equipping stakeholders with a clear understanding of both current dynamics and future possibilities.

Conclusive Insights Synthesizing Market Dynamics Technological Advancements and Strategic Imperatives Shaping the Future of Feline Leukemia Vaccination

Synthesizing the landscape of FeLV vaccination reveals a dynamic interplay between scientific innovation, regulatory frameworks, and market-driven imperatives. Technological breakthroughs in recombinant and subunit platforms have expanded the feasibility of safer, more targeted vaccines, while clinical protocols evolve to optimize patient outcomes and owner adherence. Tariff-related pressures have underscored the importance of agile supply chain strategies and flexible manufacturing models.

Segmentation insights highlight the critical roles of vaccine type, distribution pathways, and administration routes in shaping commercial success, while regional analysis underscores pronounced variations in adoption patterns and regulatory environments. Competitive profiling illuminates collaboration as a key enabler of industry progress, with partnerships fostering complementary expertise and shared resource optimization. Collectively, these findings emphasize the need for integrated, data-driven approaches that align scientific advancement with practical implementation. This conclusion affirms the strategic imperatives that will define the next chapter of FeLV vaccine development and deployment.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Vaccine Type
    • Live Attenuated Vaccine
    • Recombinant Vaccine
    • Subunit Vaccine
  • End User
    • Research Centers
    • Veterinary Clinics
    • Veterinary Hospitals
  • Distribution Channel
    • Online Stores
      • E Pharmacy
      • Manufacturer Website
    • Veterinary Clinics
    • Veterinary Hospitals
  • Administration Route
    • Intramuscular
    • Subcutaneous
  • Form
    • Liquid
    • Lyophilized
  • Dosage
    • Multi Dose
    • Single Dose
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Zoetis Inc.
  • Boehringer Ingelheim International GmbH
  • Merck & Co., Inc.
  • Elanco Animal Health Incorporated
  • Ceva Santé Animale
  • Virbac S.A.
  • Heska Corporation
  • Vetoquinol S.A.
  • Dechra Pharmaceuticals PLC
  • Bimeda, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of adjuvanted recombinant FeLV vaccines enhancing immune response
5.2. Increasing demand for single-shot combination vaccines targeting multiple feline diseases including FeLV
5.3. Growing preference for needle-free transdermal delivery systems in feline FeLV immunization protocols
5.4. Expansion of cold-chain logistics solutions to improve FeLV vaccine stability and global distribution
5.5. Surge in veterinary telehealth consultations driving FeLV vaccination awareness among cat owners
5.6. Regulatory approval of novel vector-based FeLV vaccines stimulating market competition
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. FeLV Vaccine Market, by Vaccine Type
8.1. Introduction
8.2. Live Attenuated Vaccine
8.3. Recombinant Vaccine
8.4. Subunit Vaccine
9. FeLV Vaccine Market, by End User
9.1. Introduction
9.2. Research Centers
9.3. Veterinary Clinics
9.4. Veterinary Hospitals
10. FeLV Vaccine Market, by Distribution Channel
10.1. Introduction
10.2. Online Stores
10.2.1. E Pharmacy
10.2.2. Manufacturer Website
10.3. Veterinary Clinics
10.4. Veterinary Hospitals
11. FeLV Vaccine Market, by Administration Route
11.1. Introduction
11.2. Intramuscular
11.3. Subcutaneous
12. FeLV Vaccine Market, by Form
12.1. Introduction
12.2. Liquid
12.3. Lyophilized
13. FeLV Vaccine Market, by Dosage
13.1. Introduction
13.2. Multi Dose
13.3. Single Dose
14. Americas FeLV Vaccine Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa FeLV Vaccine Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific FeLV Vaccine Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Zoetis Inc.
17.3.2. Boehringer Ingelheim International GmbH
17.3.3. Merck & Co., Inc.
17.3.4. Elanco Animal Health Incorporated
17.3.5. Ceva Santé Animale
17.3.6. Virbac S.A.
17.3.7. Heska Corporation
17.3.8. Vetoquinol S.A.
17.3.9. Dechra Pharmaceuticals PLC
17.3.10. Bimeda, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. FELV VACCINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL FELV VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL FELV VACCINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL FELV VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL FELV VACCINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL FELV VACCINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL FELV VACCINE MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL FELV VACCINE MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL FELV VACCINE MARKET SIZE, BY DOSAGE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL FELV VACCINE MARKET SIZE, BY DOSAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS FELV VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS FELV VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES FELV VACCINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES FELV VACCINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA FELV VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA FELV VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC FELV VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC FELV VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. FELV VACCINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. FELV VACCINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. FELV VACCINE MARKET: RESEARCHAI
FIGURE 28. FELV VACCINE MARKET: RESEARCHSTATISTICS
FIGURE 29. FELV VACCINE MARKET: RESEARCHCONTACTS
FIGURE 30. FELV VACCINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. FELV VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL FELV VACCINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL FELV VACCINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL FELV VACCINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL FELV VACCINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL FELV VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL FELV VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL FELV VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL FELV VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL FELV VACCINE MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL FELV VACCINE MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL FELV VACCINE MARKET SIZE, BY SUBUNIT VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL FELV VACCINE MARKET SIZE, BY SUBUNIT VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL FELV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL FELV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL FELV VACCINE MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL FELV VACCINE MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL FELV VACCINE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL FELV VACCINE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL FELV VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL FELV VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL FELV VACCINE MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL FELV VACCINE MARKET SIZE, BY ONLINE STORES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL FELV VACCINE MARKET SIZE, BY E PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL FELV VACCINE MARKET SIZE, BY E PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL FELV VACCINE MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL FELV VACCINE MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL FELV VACCINE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL FELV VACCINE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL FELV VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL FELV VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL FELV VACCINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL FELV VACCINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL FELV VACCINE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL FELV VACCINE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL FELV VACCINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL FELV VACCINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL FELV VACCINE MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL FELV VACCINE MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL FELV VACCINE MARKET SIZE, BY LYOPHILIZED, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL FELV VACCINE MARKET SIZE, BY LYOPHILIZED, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL FELV VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL FELV VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL FELV VACCINE MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL FELV VACCINE MARKET SIZE, BY MULTI DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL FELV VACCINE MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL FELV VACCINE MARKET SIZE, BY SINGLE DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS FELV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS FELV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS FELV VACCINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS FELV VACCINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS FELV VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS FELV VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS FELV VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS FELV VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES FELV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES FELV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES FELV VACCINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES FELV VACCINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES FELV VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES FELV VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES FELV VACCINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES FELV VACCINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 89. CANADA FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 90. CANADA FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 91. CANADA FELV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. CANADA FELV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. CANADA FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 94. CANADA FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 95. CANADA FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2018-2024 (USD MILLION)
TABLE 96. CANADA FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2025-2030 (USD MILLION)
TABLE 97. CANADA FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 98. CANADA FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 99. CANADA FELV VACCINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 100. CANADA FELV VACCINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 101. CANADA FELV VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 102. CANADA FELV VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 103. MEXICO FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 104. MEXICO FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 105. MEXICO FELV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. MEXICO FELV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. MEXICO FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. MEXICO FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. MEXICO FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2018-2024 (USD MILLION)
TABLE 110. MEXICO FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2025-2030 (USD MILLION)
TABLE 111. MEXICO FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 112. MEXICO FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 113. MEXICO FELV VACCINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 114. MEXICO FELV VACCINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 115. MEXICO FELV VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 116. MEXICO FELV VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL FELV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL FELV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL FELV VACCINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL FELV VACCINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL FELV VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL FELV VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA FELV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA FELV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA FELV VACCINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA FELV VACCINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA FELV VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA FELV VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA FELV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA FELV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA FELV VACCINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA FELV VACCINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA FELV VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA FELV VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA FELV VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA FELV VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM FELV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM FELV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM FELV VACCINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM FELV VACCINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM FELV VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM FELV VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 175. GERMANY FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 176. GERMANY FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 177. GERMANY FELV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. GERMANY FELV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. GERMANY FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. GERMANY FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. GERMANY FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2018-2024 (USD MILLION)
TABLE 182. GERMANY FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2025-2030 (USD MILLION)
TABLE 183. GERMANY FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 184. GERMANY FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 185. GERMANY FELV VACCINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 186. GERMANY FELV VACCINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 187. GERMANY FELV VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 188. GERMANY FELV VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 189. FRANCE FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 190. FRANCE FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 191. FRANCE FELV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. FRANCE FELV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. FRANCE FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. FRANCE FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. FRANCE FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2018-2024 (USD MILLION)
TABLE 196. FRANCE FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2025-2030 (USD MILLION)
TABLE 197. FRANCE FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 198. FRANCE FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 199. FRANCE FELV VACCINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 200. FRANCE FELV VACCINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 201. FRANCE FELV VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 202. FRANCE FELV VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 203. RUSSIA FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 204. RUSSIA FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 205. RUSSIA FELV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. RUSSIA FELV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA FELV VACCINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA FELV VACCINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA FELV VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA FELV VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 217. ITALY FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 218. ITALY FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 219. ITALY FELV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. ITALY FELV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. ITALY FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. ITALY FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. ITALY FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2018-2024 (USD MILLION)
TABLE 224. ITALY FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2025-2030 (USD MILLION)
TABLE 225. ITALY FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 226. ITALY FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 227. ITALY FELV VACCINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 228. ITALY FELV VACCINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 229. ITALY FELV VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 230. ITALY FELV VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 231. SPAIN FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 232. SPAIN FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 233. SPAIN FELV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. SPAIN FELV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. SPAIN FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. SPAIN FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. SPAIN FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2018-2024 (USD MILLION)
TABLE 238. SPAIN FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2025-2030 (USD MILLION)
TABLE 239. SPAIN FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 240. SPAIN FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 241. SPAIN FELV VACCINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 242. SPAIN FELV VACCINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 243. SPAIN FELV VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 244. SPAIN FELV VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES FELV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES FELV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES FELV VACCINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES FELV VACCINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES FELV VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES FELV VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 260. SAUDI ARABIA FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA FELV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. SAUDI ARABIA FELV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. SAUDI ARABIA FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA FELV VACCINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA FELV VACCINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA FELV VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA FELV VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 273. SOUTH AFRICA FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 274. SOUTH AFRICA FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA FELV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. SOUTH AFRICA FELV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. SOUTH AFRICA FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA FELV VACCINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA FELV VACCINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA FELV VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA FELV VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 287. DENMARK FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 288. DENMARK FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 289. DENMARK FELV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. DENMARK FELV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. DENMARK FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. DENMARK FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. DENMARK FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2018-2024 (USD MILLION)
TABLE 294. DENMARK FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2025-2030 (USD MILLION)
TABLE 295. DENMARK FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 296. DENMARK FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 297. DENMARK FELV VACCINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 298. DENMARK FELV VACCINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 299. DENMARK FELV VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 300. DENMARK FELV VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 301. NETHERLANDS FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 302. NETHERLANDS FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 303. NETHERLANDS FELV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. NETHERLANDS FELV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. NETHERLANDS FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. NETHERLANDS FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2018-2024 (USD MILLION)
TABLE 308. NETHERLANDS FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2025-2030 (USD MILLION)
TABLE 309. NETHERLANDS FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 310. NETHERLANDS FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 311. NETHERLANDS FELV VACCINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 312. NETHERLANDS FELV VACCINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS FELV VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS FELV VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 315. QATAR FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 316. QATAR FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 317. QATAR FELV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. QATAR FELV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. QATAR FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 320. QATAR FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 321. QATAR FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2018-2024 (USD MILLION)
TABLE 322. QATAR FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2025-2030 (USD MILLION)
TABLE 323. QATAR FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 324. QATAR FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 325. QATAR FELV VACCINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 326. QATAR FELV VACCINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 327. QATAR FELV VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 328. QATAR FELV VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 329. FINLAND FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 330. FINLAND FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 331. FINLAND FELV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 332. FINLAND FELV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 333. FINLAND FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 334. FINLAND FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 335. FINLAND FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2018-2024 (USD MILLION)
TABLE 336. FINLAND FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2025-2030 (USD MILLION)
TABLE 337. FINLAND FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 338. FINLAND FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 339. FINLAND FELV VACCINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 340. FINLAND FELV VACCINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 341. FINLAND FELV VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 342. FINLAND FELV VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 343. SWEDEN FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 344. SWEDEN FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 345. SWEDEN FELV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 346. SWEDEN FELV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 347. SWEDEN FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 348. SWEDEN FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 349. SWEDEN FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2018-2024 (USD MILLION)
TABLE 350. SWEDEN FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2025-2030 (USD MILLION)
TABLE 351. SWEDEN FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 352. SWEDEN FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 353. SWEDEN FELV VACCINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 354. SWEDEN FELV VACCINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 355. SWEDEN FELV VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 356. SWEDEN FELV VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 357. NIGERIA FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 358. NIGERIA FELV VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 359. NIGERIA FELV VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 360. NIGERIA FELV VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 361. NIGERIA FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 362. NIGERIA FELV VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 363. NIGERIA FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2018-2024 (USD MILLION)
TABLE 364. NIGERIA FELV VACCINE MARKET SIZE, BY ONLINE STORES, 2025-2030 (USD MILLION)
TABLE 365. NIGERIA FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 366. NIGERIA FELV VACCINE MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 367. NIGERIA FELV VACCINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 368. NIGERIA FELV VACCINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 369. NIGERIA FELV VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 370. NIGERIA FELV VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 371. EGYPT FELV VACCINE MARKET SIZE,

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this FeLV Vaccine market report include:
  • Zoetis Inc.
  • Boehringer Ingelheim International GmbH
  • Merck & Co., Inc.
  • Elanco Animal Health Incorporated
  • Ceva Santé Animale
  • Virbac S.A.
  • Heska Corporation
  • Vetoquinol S.A.
  • Dechra Pharmaceuticals PLC
  • Bimeda, Inc.

Related Topics

Related Reports

Cat Vaccines - Global Strategic Business Report - Product Image

Cat Vaccines - Global Strategic Business Report

  • Report
  • 466 Pages
  • Global
From
Tobacco Plant Vaccines Market by Vaccine Type, Application, Route Of Administration, End User, Distribution Channel, Dosage Form, Disease Indication - Global Forecast 2025-2030 - Product Image

Tobacco Plant Vaccines Market by Vaccine Type, Application, Route Of Administration, End User, Distribution Channel, Dosage Form, Disease Indication - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
5-in-1 DTaP-Hib-IPV Vaccine Market by End User (Clinics, Hospitals, Immunization Centers), Distribution Channel (Government Medical Stores, Hospital Pharmacies, Online Pharmacies), Administration Route, Dosage Form, Packaging, Age Group - Global Forecast 2025-2030 - Product Image

5-in-1 DTaP-Hib-IPV Vaccine Market by End User (Clinics, Hospitals, Immunization Centers), Distribution Channel (Government Medical Stores, Hospital Pharmacies, Online Pharmacies), Administration Route, Dosage Form, Packaging, Age Group - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Porcine Vaccines Market by Vaccine Type (Inactivated, Live Attenuated, MRNA), Disease Indication (Classical Swine Fever, Erysipelas, Porcine Reproductive and Respiratory Syndrome), End User, Route Of Administration, Technology, Dosage Form - Global Forecast 2025-2030 - Product Image

Porcine Vaccines Market by Vaccine Type (Inactivated, Live Attenuated, MRNA), Disease Indication (Classical Swine Fever, Erysipelas, Porcine Reproductive and Respiratory Syndrome), End User, Route Of Administration, Technology, Dosage Form - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Cholera Vaccines Market by Vaccine Type (Injectable Vaccine, Oral Vaccine), Route Of Administration (Intramuscular, Oral), Dosage Form, Presentation Type, Distribution Channel, End User, Age Group, Application - Global Forecast 2025-2030 - Product Image

Cholera Vaccines Market by Vaccine Type (Injectable Vaccine, Oral Vaccine), Route Of Administration (Intramuscular, Oral), Dosage Form, Presentation Type, Distribution Channel, End User, Age Group, Application - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.